Clinical Trials › NCT06220669
Active, Not RecruitingPhase 2
A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis
Sponsored by Eli Lilly and Company
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 63
Target enrollment
5
U.S. states
Mar 2024
Start date
Jul 2026
Expected completion
Interventions / Treatments
LY3541860Placebo
Conditions studied
Multiple Sclerosis
Where this trial is running (6 sites)
Florida2 sites
Gulf Breeze · Winter Park
Illinois1 site
Northbrook
Missouri1 site
Ozark
South Carolina1 site
Greer
Tennessee1 site
Knoxville
Participating MS centers on MS Buddy (2)
Hope Neurology, PLLC
Knoxville, TN
Knoxville, TN
Premier Neurology, PC
Greenville, SC
Greenville, SC
MS centers in Florida
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Florida centersMore Phase 2 trials
Browse all Phase 2 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
